(Q56342047)
Statements
Tafenoquine receives regulatory approval in U.S. for prophylaxis of malaria and radical cure of Plasmodium vivax (English)
0 references
20 August 2018
0 references
scholarly article by Kathrine R Tan & Jimee Hwang published 20 August 2018 in Journal of Travel Medicine